Name of organisation
1) Department/Research group
2) Organisation/affiliationUniversity Medical Center Utrecht
Short Name in the inventoryUMCU
Administrative Contact
Title Dr
Last name Lalmohamed
First name Arief
Address line 1Heidelberglaan 100
Address line 2
Address line 3
CityUtrecht
Postcode
CountryNetherlands
Phone number (incl. country code)+31650124509
Alternative phone number
Fax number (incl. country code)
Scientific Contact
Title Dr
Last name Lalmohamed
First name Arief
Address line 1Heidelberglaan 100
Address line 2
Address line 3
CityUtrecht
Postcode
CountryNetherlands
Phone number (incl. country code)+31650124509
Alternative phone number
Fax number (incl. country code)
2. Description
The mission of the UMCU Clinical Pharmacy research program is to explain, predict and improve patients’ response to pharmacotherapeutic treatment using pharmacoepidemiological and clinical pharmacological approaches. The research program finds its inspiration in needs and observations from daily patient care. Within this general scope, the research program focuses on three areas: children (patient group oriented), central nervous system drugs(exposure/drug group oriented), and drug induced illness (outcome oriented, i.e. side effects, toxicology, medication errors). The department of Clinical Pharmacy produces >40 peer reviewed publications per year in the area of pharmacoepidemiology, pharmacovigilence and clinical pharmacology.
3. Category
University based
Hospital based
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
Yes
Statistician
Yes
Yes
Clinician
Yes
Yes
Clinical Pharmacologist
Yes
Yes
Pharmacist
Yes
Yes
Geneticist/Pharmacogeneticist
Yes
No
IT specialist
Yes
No
Ethics expertise
Yes
No
Legal expertise
Yes
No
Regulatory expertise
Yes
No
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Disorders of the central nervous system
Geriatrics
Musculoskeletal and joint diseases
Neonates
Osteoporosis
Paediatrics
Pregnancy
Psychiatry
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Drug Utilisation
Interventional Clinical Trial
Meta-Analysis
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Greater than 5
Number of patients/respondents involved in the study(ies)
Less than 150
Between 150 and 1499
8. Access to data collection resources
Capacity to conduct face-to-face interviews
Yes
In a clinic
Yes
In the community
Yes
Electronic data capture systems
No
Interactive voice response systems
No
Call centre
No
9. Experience in secondary research and meta-analysis
Yes
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
Hospital Discharge3
PHARMO Database Network1
CPRD5
11. Registries established by centre
Drug RegistryBusulfan / stem cell transplantation
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
None